Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis
- PMID: 32245882
- DOI: 10.1136/heartjnl-2019-316343
Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis
Abstract
Objective: The European Society of Cardiology (ESC) 0/1 hour algorithm has been primarily validated in Europe, America and Australasia with less knowledge of its performance outside of these settings. We aim to evaluate the performance of the ESC 0/1 hour algorithm across different contexts.
Methods: We searched PubMed, Embase, Scopus, Web of Science and the Cochrane Central Register of Controlled Trials for relevant studies published between 1 January 2008 and 31 May 2019. The primary outcome was index myocardial infarction and the secondary outcome was major adverse cardiac event or mortality. A bivariate random-effects meta-analysis was used to derive the pooled estimate of each outcome.
Results: A total of 11 014 patients from 10 cohorts were analysed for the primary outcome. The algorithm based on high-sensitivity cardiac troponin (hs-cTn)T (Roche), hs-cTnI (Abbott) and hs-cTnI (Siemens) had pooled sensitivity of 98.4% (95% CI=95.1% to 99.5%), 98.1% (95% CI=94.6% to 99.3%) and 98.7% (95% CI=97.3% to 99.3%), respectively. The algorithm based on hs-cTnT (Roche) and hs-cTnI (Siemens) had pooled specificity of 91.2% (95% CI=86.0% to 94.6%) and 95.9% (95% CI=94.1% to 97.2%), respectively. Among patients in the rule-out category, the pooled mortality rate at 30 days and at 1 year was 0.1% (95% CI=0.0% to 0.4%) and 0.8% (95% CI=0.5% to 1.2%), respectively. Among patients in the observation zone, the pooled mortality rate was 0.7% (95% CI=0.3% to 1.2%) at 30 days but increased to 8.1% (95% CI=6.1% to 10.4%) at 1 year, comparable to the mortality rate in the rule-in group.
Conclusion: The ESC 0/1 hour algorithm has high diagnostic accuracy but may not be sufficiently safe if the 1% miss-rate for myocardial infarction is desired.
Prospero registration number: CRD42019142280.
Keywords: acute coronary syndromes; acute myocardial infarction.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: EG reports personal fees from Roche Diagnostics, personal fees from Hoffmann La Roche, personal fees from Brahms Thermo Fischer, personal fees from Daiichi Sankyo, personal fees from Astra Zeneca and personal fees from Bayer Vital outside the submitted work. C-CL reports receiving speaking honorarium from Roche Diagnostics. All other authors report no conflict of interest.
Comment in
-
High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action.Heart. 2020 Jul;106(13):955-957. doi: 10.1136/heartjnl-2020-316811. Epub 2020 Apr 27. Heart. 2020. PMID: 32341134 Free PMC article. No abstract available.
Similar articles
-
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis.Ann Intern Med. 2022 Jan;175(1):101-113. doi: 10.7326/M21-1499. Epub 2021 Nov 23. Ann Intern Med. 2022. PMID: 34807719
-
Combining High-Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction.Circulation. 2018 Sep 4;138(10):989-999. doi: 10.1161/CIRCULATIONAHA.117.032003. Circulation. 2018. PMID: 29691270
-
Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction.Heart. 2016 Aug 15;102(16):1270-8. doi: 10.1136/heartjnl-2015-308505. Epub 2016 Mar 8. Heart. 2016. PMID: 26955848
-
High-sensitivity-cardiac troponin for accelerated diagnosis of acute myocardial infarction: A systematic review and meta-analysis.Am J Emerg Med. 2020 Jul;38(7):1402-1407. doi: 10.1016/j.ajem.2019.11.035. Epub 2019 Dec 28. Am J Emerg Med. 2020. PMID: 31932131
-
Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: A meta-analysis.Medicine (Baltimore). 2016 Dec;95(52):e5703. doi: 10.1097/MD.0000000000005703. Medicine (Baltimore). 2016. PMID: 28033267 Free PMC article.
Cited by
-
From Atherosclerotic Plaque to Myocardial Infarction-The Leading Cause of Coronary Artery Occlusion.Int J Mol Sci. 2024 Jul 2;25(13):7295. doi: 10.3390/ijms25137295. Int J Mol Sci. 2024. PMID: 39000400 Free PMC article. Review.
-
Biomarkers-in-Cardiology 8 RE-VISITED-Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome-A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial.Cells. 2022 Jan 8;11(2):211. doi: 10.3390/cells11020211. Cells. 2022. PMID: 35053326 Free PMC article. Clinical Trial.
-
Performance of the 0-Hour/1-Hour Algorithm for Diagnosing Myocardial Infarction in Patients With Chest Pain in the Emergency Department - A Systematic Review and Meta-Analysis.Circ Rep. 2022 Apr 20;4(6):241-247. doi: 10.1253/circrep.CR-22-0001. eCollection 2022 Jun 10. Circ Rep. 2022. PMID: 35774074 Free PMC article. Review.
-
Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome.Clin Res Cardiol. 2021 Sep;110(9):1353-1368. doi: 10.1007/s00392-021-01821-2. Epub 2021 Feb 26. Clin Res Cardiol. 2021. PMID: 33635437 Free PMC article.
-
Cost effectiveness of a 1-hour high-sensitivity troponin-T protocol: An analysis of the RAPID-TnT trial.Int J Cardiol Heart Vasc. 2021 Dec 29;38:100933. doi: 10.1016/j.ijcha.2021.100933. eCollection 2022 Feb. Int J Cardiol Heart Vasc. 2021. PMID: 35024428 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials